MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges

Takahiro Tsuboyama, Sato K, Kazuaki Sato, Takashi Ota, Hideyuki Fukui, Hiromitsu Onishi, Atsushi Nakamoto, Mitsuaki Tatsumi, Noriyuki Tomiyama
Radiographics : a review publication of the Radiological Society of North America, Inc · 2022 · vol. 42(7) , pp. 2095–2111 · doi:10.1148/rg.220068 · PMID:36083804 · W4295078000
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study correlates MRI features of borderline epithelial ovarian tumors, including subtype-specific findings and diffusion-weighted imaging characteristics, with their pathology to aid radiologists in diagnosis despite imaging overlap with benign and malignant lesions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Borderline epithelial ovarian tumors are a distinct pathologic entity characterized by increased epithelial proliferation and nuclear atypia, but without frank stromal invasion. Borderline tumor (BT) is now considered to represent an intermediate phase in the stepwise progression from benign to malignant ovarian epithelial tumor. Since BTs commonly manifest at early stages in women of reproductive age and are associated with a good prognosis, making the correct diagnosis is important in determining whether a patient is a candidate for fertility-sparing surgery. There are six histologic BT subtypes (serous, mucinous, seromucinous, endometrioid, clear cell, and Brenner), and each has different MRI features, reflecting their unique histologic architectures. Radiologists should be aware of the MRI features that can suggest BTs. These features include a hyperintense papillary architecture with hypointense internal branching, which can be observed with serous and seromucinous BTs on T2-weighted images; aggregates of microcysts that have hypointensity on T2-weighted images and reticular enhancement on contrast-enhanced T2-weighted images, which can be seen with mucinous BTs; and moderately high signal intensity on diffusion-weighted images along with relatively high apparent diffusion coefficient values, which can be observed regardless of the histologic subtype. Nevertheless, because the imaging features of BTs overlap with those of many benign lesions (eg, cystadenoma and cystadenofibroma, decidualized endometriosis, and polypoid endometriosis) and malignant tumors (ovarian cancers and metastases), histologic confirmation is required for the final diagnosis. Special emphasis is placed on the MRI features of BTs, pathologic correlation, and the challenges related to diagnosis. ©RSNA, 2022.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma Carcinoma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (65)

Cited by (1)

Source provenance

europepmc
last seen: 2026-09-21T06:08:07.822426+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-08-26T06:08:36.431355+00:00
License: CC0 · commercial use OK